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Abstract
Background: Lymphatic filariasis can be associated with development of serious pathology in the form of lymphedema,
hydrocele, and elephantiasis in a subset of infected patients.
Methods and Findings: To elucidate the role of CD4+ T cell subsets in the development of lymphatic pathology, we
examined specific sets of cytokines in individuals with filarial lymphedema in response to parasite antigen (BmA) and
compared them with responses from asymptomatic infected individuals. We also examined expression patterns of Toll-like
receptors (TLR1–10) and Nod-like receptors (Nod1, Nod2, and NALP3) in response to BmA. BmA induced significantly higher
production of Th1-type cytokines—IFN-c and TNF-a—in patients with lymphedema compared with asymptomatic
individuals. Notably, expression of the Th17 family of cytokines—IL-17A, IL-17F, IL-21, and IL-23—was also significantly
upregulated by BmA stimulation in lymphedema patients. In contrast, expression of Foxp3, GITR, TGFb, and CTLA-4, known
to be expressed by regulatory T cells, was significantly impaired in patients with lymphedema. BmA also induced
significantly higher expression of TLR2, 4, 7, and 9 as well Nod1 and 2 mRNA in patients with lymphedema compared with
asymptomatic controls.
Conclusion: Our findings implicate increased Th1/Th17 responses and decreased regulatory T cells as well as regulation of
Toll- and Nod-like receptors in pathogenesis of filarial lymphedema.
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Introduction
Although two-thirds of the 120 million people infected with
Wuchereria bancrofti, the major causative agent of human lymphatic
filariasis, have subclinical infections,,40 million have lymphedema
and/or other pathologic manifestations including hydroceles (and
other forms of urogenital disease), episodic adenolymphangitis,
tropical pulmonary eosinophilia, lymphedema, and (in its most
severe form) elephantiasis [1]. AdultW. bancrofti worms reside in the
lymphatics and lymph nodes and induce changes that result in
dilatation of lymphatics and thickening of the lymphatic vessel walls.
Progressive lymphatic damage and pathology results from the
summation of the effect of tissue alterations induced by both living
and nonliving adult parasites, the host inflammatory response to the
parasites and their secreted antigens, the host inflammatory
response to the endosymbiont Wolbachia, and those seen as a
consequence of secondary bacterial or fungal infections [2–4].
Lymphatic damage in animal models of filarial infection has
been shown to be dependent on T cells. Thus, nude mice (lacking
T cells) and SCID mice (lacking T and B cells) exhibit only
reversible, moderate pathology that becomes irreversible and
severe upon T cell reconstitution [5,6]. Moreover, T cells have
also been shown to play a role in human lymphatic disease, with
the presence of abnormal T cell infiltrates exhibiting a biased
TCR repertoire at the site of inflammation [7,8]. T cells in
lymphedema patients are also characterized by abnormal
chemokine receptor expression, with unusually high expression
of CCR9 as well as increased surface expression of HLA-DR and
VCAM-1 [9–11]. In addition to T cells, pattern recognition
receptors of the Toll-like receptor (TLR) family—most notably
TLR2 and TLR4—have been implicated in the development of
filarial pathology [12]. In an animal model of a closely related
filarial infection, onchocerciasis, the primary cause of ocular
pathology has been suggested to be based on the interaction of the
bacterial endosymbiont Wolbachia with host TLR4 [13].
Downregulation of TLR on antigen-presenting cells (APCs) and
T cells has been shown to be a possible mechanism by which
deleterious pathology in clinically asymptomatic filarial infections
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can be circumvented [14,15]. Thus, inflammatory damage
induced by filarial parasites appears to be multifactorial, with
endogenous parasite products, Wolbachia, and host immunity all
playing important roles. The role of regulatory T cells (Treg)—
known to suppress inflammation in a variety of inflammatory and
infectious diseases—in modulating pathology caused by human
lymphatic filariasis is not known.
While the nature of immune responses to parasite antigens has
been well characterized in patients with the asymptomatic (or
subclinical) form of filarial infection, the type of T cell responses
(Th1/Th2/Th17/natural Treg [nTreg]) that characterizes devel-
opment of filarial pathology is less well studied. We therefore
examined the expression patterns of Th1 (IL-2, IFN-c, and TNF-
a), Th2 (IL-4 and IL-13) and IL-10, Th17 (IL-17A, IL-17B, IL-21,
IL-22, and IL-23), and nTreg (Foxp3, GITR, TGFb, and CTLA-
4) markers in filarial lymphedema patients and asymptomatic
infected individuals following stimulation with parasite and control
antigens. In addition, because of the putative causative role of
TLRs in animal models of filarial pathology, we have examined
the regulation of TLR expression as well as the expression of a
closely related pattern recognition receptor family—Nod-like
receptor (NLR).. We show that lymphatic disease in human
filariasis is characterized by increased antigen-driven Th1 and
Th17 cytokine induction, impaired Treg induction, and enhanced
mRNA expression of both TLR and NLR family members.
Methods
Study population
We studied a group of 12 patients with filarial lymphedema
(hereafter CP) and 10 asymptomatic infected (hereafter INF)
patients in an area endemic for lymphatic filariasis in Tamil Nadu,
South India (Table 1). CP patients were circulating filarial antigen
negative by both the ICT filarial antigen test (Binax, Portland,
ME) and the TropBio Og4C3 enzyme-linked immunosorbent
assay (ELISA) (Trop Bio Pty. Ltd, Townsville, Queensland,
Australia), indicating lack of current active infection. They had
undergone treatment with repeated doses of diethylcarbamazine.
The diagnosis of prior filarial infection was made by history and
clinical examination as well as positive Brugia malayi antigen
(BmA)-specific IgG4. BmA-specific IgG4 and IgG ELISA were
performed exactly as described previously [16]. INF patients tested
positive for active infection by both the ICT filarial antigen test
and the TropBio Og4C3 ELISA. All individuals were examined as
part of a clinical protocol approved by Institutional Review Boards
of both the National Institutes of Allergy and Infectious Diseases
and the Tuberculosis Research Center, and informed written
consent was obtained from all participants.
Isolation of peripheral blood mononuclear cells (PBMCs)
Heparinized blood was collected and PBMCs isolated by Ficoll
diatrizoate gradient centrifugation (LSM; ICN Biomedicals,
Aurora, OH). Erythrocytes were lysed using ACK lysis buffer
(Biosource International, Camarillo, CA). Cells were then washed
and cultured in RPMI-1640 (BioWhittaker, Walkersville, MD)
supplemented with 20 mM glutamine (BioWhittaker), 10% heat-
inactivated FCS (Harlan Bioproducts for Science), and 50 mg/ml
of gentamycin (Mediatech, Herndon, VA).
Parasite and control antigen
Saline extracts of B. malayi adult worms (BmA) were used as the
parasite antigen and mycobacterial PPD (Serum Statens Institute,
Table 1. Characteristics of the study population.
Filarial lymphedema (n=12) Infected (n=10)
Median Age (Range) 49 (38–63) 32 (21–50)
Gender M / F 8 / 4 6 / 4
Treatment Yes No
Pathology Grade 2 Lymphedema – 4 None
Grade 3 Lymphedema –4
Grade 4 Lymphedema – 4
W. bancrofti circulating antigen levels U/ml* (Median) ,32 (,32) 1307–32768 (18305)
BmA-specific IgG (mg/ml) (GM) 1.51–82.44 (11.74) 17.1–152.6 (54.2)
BmA-specific IgG4 (ng/ml) (GM) 441–2072 (810.4) 4293–21566 (9432.4)
*The lower limit of the assay detection was 32 U/ml.
doi:10.1371/journal.pntd.0000420.t001
Author Summary
Lymphatic filariasis afflicts over 120 million people
worldwide. While the infection is mostly clinically asymp-
tomatic, approximately 40 million people suffer from overt,
morbid clinical pathology, characterized by swelling of the
scrotal area and lower limbs (hydrocele and lymphedema).
Host immunologic factors that determine susceptibility of
this subset of individuals to clinically apparent disease is
unknown. We addressed this issue by comparing the
immunologic response of helper T (Th) cell subsets in
lymphedema patients and clinically asymptomatic individ-
uals. Four important subsets of Th cells (CD4+ T cells) are:
Th1 cells, characterized by production of cytokines IL-2,
IFN-c, and TNF-a; Th2 cells, characterized by production of
cytokines IL-4 and IL-13; Th17 cells, characterized by
production of cytokines IL-17A, IL-17F, IL-21, and IL-22; and
regulatory T cells (Tregs), characterized by the expression
of transcription factor Foxp3, as well as other molecules
such as GITR, TGFb, and CTLA-4. We determined that Th1
and Th17 responses are significantly enhanced and Treg
responses significantly impaired in lymphedema patients.
This is accompanied by increased expression of pattern
recognition receptors of the Toll and NOD family. Thus,
approaches toward downregulating Th1 and Th17 re-
sponses and enhancing Treg responses would be benefi-
cial in protecting against development of lymphatic
disease.
Th17/Tregs in Filarial Lymphedema
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Copenhagen, Denmark) was used as the control antigen. Final
concentrations were 10 mg/ml for BmA and 10 mg/ml for PPD.
Endotoxin level of final soluble BmA was ,0.1 EU/ml using the
QCL-1000 Chromogenic LAL test kit (BioWhittaker).
In vitro culture
PBMCs were cultured with BmA or PPD in 24-well tissue
culture plates (Corning, Corning, NY) at concentrations of 56106/
well. After 24 hours, culture supernatants were collected and
analyzed for cytokines.
ELISA
The levels of cytokines in the culture supernatants were
measured using Bioplex multiplex cytokine assay system (Biorad,
Hercules, CA). The cytokines analyzed were IL-2, IFN-c, TNF-a,
IL-4, IL-6, IL-10, and IL-13.
RNA preparation
RNA was isolated from PBMC following culture with BmA or
PPD for 24 h. PBMCs were lysed using the reagents of a
commercial kit (QIAshredder; Qiagen, Valencia, CA). Total RNA
was extracted according to the manufacturer’s protocol (RNeasy
mini kit; Qiagen), and RNA was dissolved in 50 ml of RNase-free
water.
cDNA synthesis
RNA (1 mg) was used to generate cDNA using TaqMan reverse
transcription reagents according to the manufacturer’s protocol
(Applied Biosystems, Fullerton, CA). Briefly, random hexamers
were used to prime RNA samples for reverse transcription using
MultiScribe reverse transcriptase.
Real-time RT-PCR
Real-time quantitative RT-PCR was performed in an ABI 7500
sequence detection system (Applied Biosystems) using TaqMan
Assays on Demand reagents for IL-17A, IL-17F, IL-21, IL-22, IL-
23, Foxp3, GITR, TGFb, CTLA-4, TLR1-10, Nod1, Nod2,
NALP3 and an endogenous 18 s ribosomal RNA control. Relative
transcripts were determined by the formula
1
.
2 CTtarget{CTcontrolð Þ,
where CT is the threshold cycle during the exponential phase of
amplification, according to the manufacturer’s protocol.
Statistical analysis
Comparisons were made using the Mann-Whitney U test. All
statistics were performed using GraphPad Prism version 5 for
Windows (GraphPad Software, Inc., San Diego, CA).
Results
Filarial antigen induces augmented Th1 responses in CP
patients
To determine the role of Th1 cytokines in development of
lymphedema, we stimulated PBMCs from CP and INF patients
with BmA or PPD for 24 hours and measured the levels of
prototypical Th1 cytokines by ELISA. As shown in Figure 1A,
BmA induced significantly increased production of IFN-c
(geometric mean [GM] of 956.8 pg/ml in CP vs. 24.88 pg/ml
in INF; P,0.0001) and TNF-a (GM of 200.2 vs. 25.64;
P = 0.0033) but not IL-2 (GM of 501.5 vs. 308.5) in CP compared
with INF. As shown in Figure 1B, no significant alteration in the
production of IFN-c (GM of 659.1 vs. 707.7), TNF-a (GM of
185.0 vs. 428.5), and IL-2 (GM of 296.5 vs. 210.8) was observed in
response to the control antigen PPD. Thus, elevated Th1
responses in CP patients were filarial-antigen specific.
Filarial antigen does not induce differential Th2 or IL-10
responses in CP patients
Patients with lymphedema exhibited Th2 or IL-10 responses to
filarial antigen that were no different than the Th2 or IL-10
responses seen in INF patients (Figure 2A). Upon stimulation with
BmA, PBMCs from CP patients produced levels of IL-4 (GM of
480.0 vs. 438.2), IL-13 (GM of 119.2 vs. 151.7), and IL-10 (GM of
281.2 vs. 321.6) not significantly different from those from INF
patients. Similarly, in response to PPD, no significant alteration in
the levels of IL-4 (GM of 324.8 vs. 215.8), IL-13 (GM of 32.09 vs.
50.65), and IL-10 (GM of 178.9 vs. 130.4) was observed
(Figure 2B).
Filarial antigen induces enhanced expression of the IL-17
cytokine family in CP patients
To address the role of Th17 cells in filarial lymphedema, we
examined the expression of IL-17A, IL-17F, IL-21 and IL-22 as
well as the upstream inducing cytokines IL-23, IL-6 and IL-1b in
PBMCs of lymphedema patients following BmA or PPD
stimulation. As shown in Figure 3, PBMCs from CP patients
exhibited significant upregulation of IL-17A (GM fold change of
8.125 vs. 1.456; P= 0.0076), IL-17F (GM fold change of 3.003 vs.
0.8710; P= 0.0122), IL-21 (GM fold change of 5.629 vs. 1.460;
P= 0.0222), and IL-23 (GM fold change of 2.771 vs. 0.3222;
P= 0.0009) mRNA expression compared with INF patients.
Again, this upregulation was filarial-antigen specific, as there were
no significant differences in the expression of IL-17A (GM fold
change of 2.841 vs. 3.723), IL-17F (GM fold change of 1.711 vs.
1.293), IL-21 (GM fold change of 4.250 vs. 2.502), or IL-23 (GM
fold change of 1.799 vs. 2.913) in response to PPD (Figure 3C and
3D) between the two groups. IL-22 was the only IL-17 family
cytokine whose production did not differ between the two groups
upon stimulation with BmA (GM fold change of 1.081 vs. 0.9531).
In addition, BmA and PPD induced levels of cytokines upstream of
the IL-17 axis - IL-6 (GM of 1895 pg/ml vs. 1664 pg/ml for
BmA; 1189 vs. 1429 for PPD) and IL-1b (GM of 972.7 vs. 551.7
for BmA; 1758 vs. 1284 for PPD) that did not differ between the
two groups.
Impaired expression of nTreg markers in CP patients
To determine the role of nTregs in the development of
lymphedema, we stimulated PBMCs from CP and INF patients
with BmA or PPD for 24 h and examined the mRNA expression
of nTreg markers—Foxp3, GITR, TGFb, and CTLA-4—by real-
time RT-PCR. As shown in Figure 4A, CP exhibit significantly
lower induction of Foxp3 (GM fold change of 1.377 vs. 4.1613;
P= 0.0014), GITR (GM fold change of 1.223 vs. 7.462;
P= 0.0003), TGFb (GM fold change of 0.8928 vs. 3.118;
P= 0.0003) and CTLA-4 (GM fold change of 0.5807 vs. 3.702;
P= 0.0002) in response to BmA in comparison with INF. As
shown in Figure 4B, no significant alteration in the expression of
Foxp3 (GM fold change of 1.047 vs. 1.154), GITR (GM fold
change of 1.022 vs. 1.488), TGFb (GM fold change of 1.537 vs.
1.944) and CTLA-4 (GM fold change of 1.964 vs. 1.986) was
observed in response to the control antigen, PPD. Thus, a failure
of induction of nTregs was characteristic of antigen-driven
responses in filarial lymphedema.
Th17/Tregs in Filarial Lymphedema
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Filarial antigen induces enhanced TLR expression in CP
patients
Because TLR have been implicated in development of
pathology in animal models of filarial parasites as well as in a
related filarial infection, onchocerciasis [4], we sought to
determine the role of TLR expression in development of filarial
lymphedema by examining the expression patterns of all ten
human TLRs in PBMCs of CP and INF patients following 24-
hour stimulation with BmA or PPD. As shown in Figure 5, CP
exhibit significantly higher induction of BmA-stimulated TLR2
(GM fold change of 1.470 vs. 0.7357; P = 0.0068), TLR4 (GM fold
change of 1.146 vs. 0.5216; P = 0.0176), TLR7 (GM fold change
of 1.049 vs. 0.4361; P= 0.0377) and TLR9 (GM fold change of
1.217 vs. 0.6622; P= 0.0377) expression in comparison with INF.
No significant alteration in the expression of other TLRs was
observed in response to BmA (Figure 5). No significant difference
in the expression levels of TLRs was observed in response to PPD
stimulation (data not shown).
Filarial antigen induces significantly increased expression
of Nod1 and Nod2 in CP patients
NLRs are cytosolic proteins that play a role in regulation of
proinflammatory pathways through NF-kB induced by bacterial
ligands [17]. Three family members—Nod1, Nod2, and
NALP3—have been shown to be particularly important in this
process [17]. To elucidate the role of NLR in response to filarial
antigen, we examined induction of Nod1, Nod2, and NALP3
following 24-hour stimulation with BmA or PPD in CP and INF
patients (Figure 6). We found that BmA (but not PPD) induced
significantly higher expression of Nod1 (GM fold change of 1.582
vs.0.1236; P,0.0001) and Nod2 (GM fold change of 1.518 vs.
0.1918; P= 0.0062) but not NALP3 (GM fold change of 1.108 vs.
1.071) in CP compared to INF patients.
Discussion
The role of cytokines in inflammation is well established, and
anticytokine therapies such as anti-TNF-a are now used routinely
to treat chronic inflammatory diseases [18,19]; however, to
understand the underlying disease mechanisms so that more
directed therapeutics might be developed, it was necessary to
identify the cytokine networks that regulate the development of
pathology. The Th1/Th2 framework has been useful in the
understanding of infectious and allergic disease processes, but for
inflammatory and autoimmune diseases, Th1 cells—clearly
important in pathogenesis—are not the only subset promoting
pathologic reactions [20]. Characterization of Th17 cells has
furthered our understanding of the pathogenesis of many
inflammatory and autoimmune disorders [20]. Th17 cells,
characterized by expression of cytokines IL-17A and IL-17F as
well as IL-21 and IL-22, are developmentally influenced in mice
by IL-6, IL-21, IL-23, and TGFb and in humans by IL-6, IL-1b,
IL-23, and TGFb [21]. Together with Th1 cells, Th17 cells play
Figure 1. Filarial lymphedema is associated with elevated Th1 cytokine secretion. (A, B) PBMCs from filarial lymphedema [CP] (n=12) and
asymptomatic infected [INF] (n = 10) patients stimulated with (A) BmA (10 mg/ml) or (B) PPD (10 mg/ml) for 24 hours, and Th1 - IL-2, IFN-c, and TNF-a
cytokine levels were measured by ELISA. Results are shown as net cytokine production over media control. P values were calculated using the Mann-
Whitney test.
doi:10.1371/journal.pntd.0000420.g001
Th17/Tregs in Filarial Lymphedema
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an important role in the establishment/maintenance of a variety of
chronic inflammatory and autoimmune disorders [22]. Thus,
chronic inflammatory responses in experimental autoimmune
encephalomyelitis and collagen-induced arthritis are mediated by
the IL-23-IL-17 axis [22], as are some of the immune-mediated
pathology in murine schistosomiasis [23,24] and toxoplasmosis
[25]. nTregs are crucial in the maintenance of peripheral immune
tolerance [26] and also play an important role in downregulating
immune responses engendered by invading pathogens [27]. The
ability to regulate potent immune responses following elimination
of the pathogen is a major factor in limiting immune-mediated
pathology in a variety of bacterial, viral, fungal and parasitic
infections [27].
Lymphatic filariasis is a disease characterized by a broad
spectrum of clinical manifestations including an asymptomatic (or
subclinical) form seen among the majority of infected people [1].
The immune response in clinically asymptomatic individuals is
dominated by IL-4, IL-5, IL-10, and IL-13 secretion, IgE and
IgG4 antibodies, and peripheral eosinophilia [1]. A subset of
individuals with this infection, however, has demonstrable
pathology characterized, most notably, by lymphedema, hydro-
cele, and elephantiasis. To help elucidate whether filaria-induced
pathogenic reactions were caused by unchecked pro-inflammatory
(Th1/Th17) responses or by a failure to regulate these responses or
pathology, we examined the contribution of Th1, Th2, Th17, and
nTreg subsets in the development of filarial lymphedema.
Our finding that Th1 and Th17 responses are induced in
patients with filarial pathology has clear implications. IFN-c
and TNF-a are potent stimulators of nitric oxide and other
pro-inflammatory mediators of inflammation in a variety of cell
types and hence could contribute directly to development of
the pathology [28]. Th17 cells also contribute to inflammatory
pathology through induction of IL-17A, IL-17F, IL-21, and IL-
22 [22]. In our study, we found augmented induction of IL-
17A, IL-17F, IL-21, and IL-23 in patients with filaria-induced
lymphedema. IL-6 and IL-1b are two cytokines previously
shown to be important for Th17 lineage commitment [20]; the
fact that patients with or without pathology had equivalent
production of these two cytokines suggests that establishment of
the Th17 lineage is not what is altered in CP patients;
however, the increased induction of IL-23 in these same
patients does indicate that peripheral differentiation of com-
mitted Th17 cells is significantly enhanced. Most effector
cytokines known to be produced by Th17 cells—IL-17A, IL-
17F, and IL-21 (with the exception of IL-22)—are induced at
significantly higher levels in patients with lymphedema,
suggesting an important role for these cytokines in development
of this disease process. Both Th1 and Th17 cells are known to
induce production of two vascular endothelial growth factors of
the VEGF family, VEGF-C and VEGF-D [29]. Enhanced
production of VEGF-C has been implicated in development of
filarial lymphedema [30,31] and, hence, increased induction of
Th1/Th17 responses might translate into increased VEGF-C
production in the lymphedema patients in our study. Thus, the
induction of these factors could have a direct effect on
lymphatic vessel function or morphology leading to lymphatic
Figure 2. Filarial lymphedema is not associated with elevated Th2 cytokine secretion. (A, B) PBMCs from filarial lymphedema [CP] (n = 12)
and asymptomatic infected [INF] (n = 10) patients stimulated with (A) BmA (10 mg/ml) or (B) PPD (10 mg/ml) for 24 hours, and Th2 - IL-4 and IL-13, as
well as IL-10, cytokine levels were measured by ELISA. Results are shown as net cytokine production over media control. P values were calculated
using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000420.g002
Th17/Tregs in Filarial Lymphedema
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Figure 3. Filarial lymphedema is associated with enhanced expression of the IL-17 family of cytokines. PBMC expression of IL-17A, IL-
17F, IL-21 and IL-22 mRNA as measured by real-time RT-PCR following 24-hour stimulation with (A) BmA or (C) PPD and PBMC secretion of IL-6 and IL-
1b as measured by ELISA and IL-23 mRNA as measured by real-time RT-PCR following 24-hour stimulation with (B) BmA or (D) PPD in filarial
lymphedema [CP] (n = 12) and asymptomatic infected [INF] (n = 10) patients. Results are depicted as net cytokine production or as fold change over
media control. P values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000420.g003
Figure 4. Filarial lymphedema is associated with lack of Foxp3, GITR, TGFb, and CTLA-4 upregulation. (A, B) PBMCs from filarial
lymphedema [CP] (n = 12) and asymptomatic infected [INF] (n = 10) patients were stimulated with (A) BmA (10 mg/ml) or (B) PPD (10 mg/ml) for
24 hours, and Foxp3, GITR, TGFb, and CTLA-4 mRNA were measured by real-time RT-PCR. Results are shown as fold change over media control. P
values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000420.g004
Th17/Tregs in Filarial Lymphedema
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dysfunction and secondary lymphedema. Study of expression of
the VEGF family of molecules in filarial lymphedema patients
is currently under way.
Pro-inflammatory pathology in a variety of settings is offset by the
induction of a specific subset of T cells called natural or induced
Tregs [26]. nTregs are characterized by expression of the
Figure 5. Filarial lymphedema is associated with increased expression of TLR2, 4, 7 and 9 mRNA. PBMCs from filarial lymphedema [CP]
(n = 12) and asymptomatic infected [INF] (n = 10) patients were stimulated with BmA (10 mg/ml) for 24 hours, and TLR1-10 mRNA were measured by
real-time RT-PCR. Results are shown as fold change over media control. P values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000420.g005
Th17/Tregs in Filarial Lymphedema
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transcription factor Foxp3, which is absolutely essential for the
induction and maintenance of these cells [26]. GITR, a surface
molecule present on nTregs, is known to contribute to the inhibitory
function of these cells [32]. TGFb and IL-10 are regulatory
cytokines important in the induction of Treg activity as well [33].
Finally, CTLA-4 has been shown to be crucial in the maintenance
of nTreg function [34]. We and others have previously shown that
nTregs are important in the establishment of chronic infections in
humans and animal models [35,36]. Our results show that while
Foxp3, GITR, TGFb, and CTLA-4 are significantly upregulated in
patients with asymptomatic infection, there is a significant lack of
upregulation in filarial lymphedema patients. Hence, the patho-
genesis of lymphatic pathology in filarial infections appears two
pronged, with enhancement of pro-inflammatory networks (Th1
and Th17) on the one hand and depression of an anti-inflammatory
subset of cells (nTreg) on the other.
When examining the pathways leading to initiation of the
inflammatory cytokine cascade, the innate immune receptors
commonly associated with initiation of inflammatory processes are
the IL-1R- TLR and the NLR families [37,38]. Studies in animal
models of filarial infection and in vitro studies in humans have
suggested that Wolbachia-derived molecules from filarial parasites
are key inducers of proinflammatory cytokines [12,13,39].
Moreover, this inflammatory response to Wolbachia has been
shown to be mediated primarily through TLR2, TLR4, and
TLR6 [12,40]. Indeed, TLR downregulation appears to be a
mechanism of immune dysfunction in patent filarial infections
[14,15]. In addition, exposure of human dendritic cells to live
filarial parasites has been shown to downregulate the expression
and function of TLR3 and TLR4 [41]. The human TLR family
includes ten members, TLR1–10, all of which play an important
role in recognition of pathogen-associated molecular patterns. Our
data reveal that modulation of TLR expression is an important
feature of chronic lymphatic pathology since patients with
lymphedema exhibit significantly enhanced expression of TLR2,
4, 7 and 9 mRNA in comparison to asymptomatic, infected
patients. Increased expression of TLRs might potentially lead to
increased expression of pro-inflammatory cytokines and promote
pathology development. Studies to examine the functional effects
of altered TLR gene expression in patients with filarial
lymphedema are currently underway. A related family of pattern
recognition receptors is the NLR, including Nod1, Nod2, and
NALP3, among others. NLRs are intracellular proteins involved in
recognition of intracellular pathogens as well as in activation of
NF-kB and caspase-dependent pathways [42]. NLRs function as
cytosolic sensors for induction of apoptosis, innate recognition of
microorganisms, and regulation of inflammatory responses [42].
Our finding that Nod1 and Nod2 gene expression is upregulated
in an antigen-specific manner in CP patients indicates that these
cytosolic sensors are crucial in the inflammatory cascade
associated with tissue damage in the lymphatics. Further
experiments are needed to verify the cause-effect relationship
between NLR family members and development of pathology in
lymphatic filariasis.
In summary, our study examines in depth the complex cytokine
patterns involved in the pathogenesis of filarial lymphedema. We
have elucidated important roles for both Th1 and Th17 cells in
driving the inflammatory pathology and have also unraveled a role
Figure 6. Filarial lymphedema is associated with increased expression of Nod1 and Nod2 mRNA. PBMCs from filarial lymphedema [CP]
(n = 12) and asymptomatic infected [INF] (n = 10) patients were stimulated with BmA (10 mg/ml) for 24 hours, and Nod1, Nod2 and NALP3 mRNA
were measured by real-time RT-PCR. Results are shown as fold change over media control. P values were calculated using the Mann-Whitney test.
doi:10.1371/journal.pntd.0000420.g006
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for Tregs by demonstrating a lack of induction of these cells in
patients with filarial lymphedema. Thus, increased induction of
Th1 and Th17 cytokines with diminished activity of nTreg is
clearly associated with development of lymphatic pathology. In
addition, we have also discovered an association of pathology and
cytokine production with transcriptional regulation of TLRs and
NLRs, providing evidence that both membrane-bound and
cytosolic pattern recognition receptors might be involved in
inflammatory filarial pathology. Further elucidation of the exact
roles played by these ‘sensors’ should provide new clues toward
prevention of this debilitating disease through immune manipu-
lation.
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